School of Medicine


Showing 1-4 of 4 Results

  • Bruce T. Adornato

    Bruce T. Adornato

    Adjunct Clinical Professor, Neurology & Neurological Sciences

    Bio Dr. Adornato joined the Department of Neurology as Voluntary Clinical Faculty in 1978, (subsequently Adjunct Clinical Faculty) and has served as Director of the Neuromuscular Laboratory from 1978 until 1983, performing and interpreting nerve and muscle biopsies as well as serving as attending physician directing residents and medical students in the diagnosis and care of his private patients admitted to Stanford Hospital. Since 1986, he has been attending physician at the Palo Alto VA Hospital, directing Stanford Neurology residents and medical students in the care of veterans. He has published 69 peer reviewed papers and a number of book chapters in the field of neurology. He is currently the medical officer of a silicon valley startup exploring mobility devices for the neurologically impaired.

  • Gregory W. Albers, MD

    Gregory W. Albers, MD

    The Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery at the Stanford University Medical Center

    Current Research and Scholarly Interests Our group’'s research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of advanced imaging techniques to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.

  • Katrin Andreasson

    Katrin Andreasson

    Professor of Neurology at the Stanford University Medical Center

    Current Research and Scholarly Interests Our research focuses on understanding how immune responses initiate and accelerate synaptic and neuronal injury in age-related neurodegeneration, including models of Alzheimer's disease and Parkinson's disease. We also focus on the role of immune responses in aggravating brain injury in models of stroke. Our goal is the identification of critical immune pathways that function in neurologic disorders and that can be targeted to elicit disease modifying effects.